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of Hematology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, CanadaAdministration of human cord blood endothelial colony-
forming cells (ECFCs) or their exosomes protects mice
against kidney ischemia/reperfusion injury. Here we
studied the microRNA (miRNA) content of ECFC exosomes
and the role of miRNA transfer in kidney and endothelial
cell protection. ECFC exosomes were enriched in miR-486-
5p, which targets the phosphatase and tensin homolog
(PTEN) and the Akt pathway. In cultured endothelial cells
exposed to hypoxia, incubation with ECFC exosomes
increased miR-486-5p, decreased PTEN, and stimulated
Akt phosphorylation. Exposure of hypoxic endothelial
cells to conditioned medium from ECFCs pretreated with
anti–miR-486-5p blocked increases in miR-486-5p and
phosphorylated Akt, restored expression of PTEN, and
enhanced apoptosis. Coculture of endothelial cells with
ECFCs enhanced endothelial miR-486-5p levels. Targeting
of PTEN by miR-486-5p was observed in endothelial cells,
and PTEN knockdown blocked apoptosis. In mice with
ischemic kidney injury, infusion of ECFC exosomes induced
potent functional and histologic protection, associated
with increased kidney miR-486-5p levels, decreased PTEN,
and activation of Akt. Infusion of exosomes from ECFCs
transfected with anti–miR-486-5p had no protective effect.
Thus, delivery of ECFC exosomes reduces ischemic kidney
injury via transfer of miR-486-5p targeting PTEN. Exosomes
enriched in miR-486-5p could represent a therapeutic tool
in acute kidney injury.
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1238I schemia/reperfusion (IR) is a major cause of acute kidneyinjury (AKI) in humans, and is associated with tubular cellnecrosis and endothelial cell dysfunction and loss.1–3 No
treatments have been shown to accelerate kidney repair in
humans. In experimental AKI administration of certain stem
or progenitor cells improves kidney histologic and functional
recovery with no requirement for cell engraftment, indicating
that repair pathways may be activated by paracrine factors
released by the cells.4–6 Because IR causes signiﬁcant vascular
injury leading to capillary loss, the administration of cells of
endothelial lineage has been studied as a possible therapeutic
approach.5,7 In this regard, endothelial colony-forming cells
(ECFCs) are early lineage endothelial progenitors that can
be isolated from human cord blood or peripheral blood.8
We recently demonstrated that administration of human
cord blood ECFCs to nonobese diabetic severe combined
immunodeﬁcient (NOD-SCID) mice with IR AKI exerted
protective effects, with diminished levels of tubular necrosis,
apoptosis, oxidative stress, and inﬂammatory cell inﬁltrate.9
Notably, delivery of small extracellular vesicles (exosomes)
derived from ECFCs to mice also protected against kidney
injury and inhibited apoptosis in cultured endothelial cells
exposed to hypoxia/reoxygenation (HR).9 These ﬁndings are
consistent with the beneﬁcial effects of stem cell– or progen-
itor cell–derived vesicles on kidney recovery in other rodent
models of AKI.10–13
MicroRNAs (miRNAs) are 18- to 25-nucleotide RNA
species that have profound effects on protein translation via
binding to complementary regions of mRNA, usually in the 30
untranslated region (UTR).14 Extracellular vesicles selectively
package miRNA species, and the transfer of miRNAs from
cell-derived vesicles to recipient cells can regulate protein
expression and contribute to reparative signaling responses.15
In experimental AKI, depletion of proangiogenic miR-126
and miR-296 from extracellular vesicles derived from
human endothelial progenitor cells inhibited their kidney
reparative effects in vivo and reduced their antiapoptotic
effects in cultured cells.12 In mice with glycerol-induced AKI,
global depletion of miRNAs from mesenchymal stromal cell–
derived extracellular vesicles by Drosha knockdown blocked
their beneﬁcial effects on kidney functional and morphologic
recovery.16 Thus, miRNA transfer from extracellular vesicles
may be involved in accelerating repair after AKI.Kidney International (2016) 90, 1238–1250
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Figure 1 | Characterization of human endothelial colony-forming cell (ECFC)–derived exosomes (EX) and microparticles (MP). Shown
are size distributions of exosome (a) and MP (b) fractions isolated from ECFC conditioned medium by nanoparticle analysis. Data are
mean  SEM; n ¼ 3. (c) Western blot analysis identiﬁed the exosome marker Tumor Susceptibility Gene 101 (TSG101) in exosomes but not
MP fractions. *P < 0.001 versus MP. Data are presented as mean  SEM; n ¼ 3.
JL Viñas et al.: ECFC exosomes transfer miR-486-5p bas i c re sea r chIn the current studies, we determined the role of exosomal
miRNA transfer in the protective effects on IR injury. Using
Next Generation Sequencing, we deﬁned the differential
miRNA expression pattern in 2 classes of ECFC-derivedKidney International (2016) 90, 1238–1250extracellular vesicles: exosomes (40- to 100-nm diameter)
and microparticles (MPs, 100- to 1000-nm diameter). Our
results indicate an abundance of miR-486-5p within ECFC
exosomes and suggest a role in recovery from IR injury in vivo1239
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Figure 2 | Endothelial colony-forming cell (ECFC) exosomes are highly enriched in miR-486-5p. (a) Table shows the 10 most abundant
microRNAs (miRNAs) in ECFC exosomes compared with microparticles (MP). (b) miR-486-5p levels in ECFC exosomes (EX) and MP, by real-time
polymerase chain reaction. *P <0 .001; n ¼ 3.
bas i c re sea r ch JL Viñas et al.: ECFC exosomes transfer miR-486-5pand protection against endothelial cell apoptosis in vitro via
miRNA transfer and targeting of phosphatase and tensin
homolog (PTEN), with activation of Akt.
RESULTS
Characterization of miRNAs in ECFC-derived extracellular
vesicles
We ﬁrst characterized small RNA libraries from ECFCs and
their exosomes and MPs. Exosomes had a mean diameter of
91 nm and expressed the surface marker TSG101, whereas
MPs had a mean diameter of 224 nm and lacked TSG101
(Figure 1). After eliminating transfer RNA, 158 miRNAs were
isolated by Next Generation Sequencing. Although the
majority of miRNAs was common to vesicles and ECFCs, a
smaller fraction was unique to exosomes, MPs, or ECFCs
(Supplementary Figure S1). Exosome and MP miRNAs
were ranked according to enrichment based on data from 2
independent sets of miRNA libraries. In ECFC exosomes,
miR-486-5p was found at levels 289-fold higher than in MPs
(and 30-fold higher than ECFC levels) (Figure 2). The next
highest differentially expressed exosome miRNAs were found
at levelsw4-fold higher than in MPs. The differential levels of
miR-486-5p between exosomes and MPs were also evident by
real-time polymerase chain reaction (PCR) (P < 0.001)
(Figure 2). Further studies therefore focused on the role of
exosomal miR-486-5p in ischemic injury.1240Role of miR-486-5p in endothelial protection against HR
injury
In cultured human umbilical vein endothelial cells
(HUVECs) exposed to HR, administration of ECFC-derived
conditioned medium or exosomes signiﬁcantly increased
miR-486-5p levels, whereas conditioned medium from
ECFCs transfected with antagomiR to miR-486-5p blocked
this increase (Figure 3a). PTEN, a potential target of
miR-486-5p, is involved in apoptotic signaling through the
prosurvival Akt pathway.17,18 HR signiﬁcantly increased
PTEN expression, an effect blocked by ECFC-derived exo-
somes (Figure 3b). Phosphorylation of Akt was not signiﬁ-
cantly altered in HUVECs exposed to HR. However,
administration of ECFC-derived exosomes stimulated Akt
phosphorylation (Figure 3c).
We reported that ECFC-derived exosomes (but not
MPs) inhibit caspase-3 activation induced by HR in
HUVECs.9 To determine the potential role of miR-486-5p
transfer from ECFC exosomes in endothelial protection,
HUVECs were subjected to HR and exposed to condi-
tioned medium from ECFCs that had been transfected
with or without antagomiR to miR-486-5p. As shown in
Figure 4a, HR-stimulated PTEN expression was blocked by
ECFC-derived conditioned medium. By contrast, condi-
tioned medium from ECFCs transfected with antagomiR to
miR-486-5p failed to inhibit HR-mediated increases inKidney International (2016) 90, 1238–1250
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Figure 3 | Endothelial colony-forming cell (ECFC)–derived exosomes increase miR-486-5p levels, decrease phosphatase and tensin
homolog (PTEN), and enhance Akt phosphorylation in cultured endothelial cells subjected to hypoxia/reoxygenation (HR). (a) Effect of
ECFC-derived conditioned medium (CM) or exosomes on miR-486-5p levels in human umbilical vein endothelial cells (HUVECs). ECFC-derived
CM or exosomes (EX, 20 mg/ml) increased miR-486-5p levels in HUVECs subjected to HR compared with untreated HUVECs (C/HR). CM from
ECFCs transfected with anti-miR-486-5p antagomiR (AmiR) (CMþAmiR/HR) blocked increases in miR-486-5p. SCB, transfection with scrambled
miRNA sequence; LF, treatment with Lipofectamine alone. *P < 0.05, **P < 0.01 versus C/HR; þP < 0.05 versus CMþLF/HR and EX/HR; n ¼ 3. (b)
Effect of ECFC-derived exosomes (EX) on PTEN expression in HUVECs exposed to HR. *P < 0.01 versus normoxic HUVECs (C) or HRþEX; n ¼ 3. (c)
Effect of ECFC-derived exosomes (EX) on phosphorylated Akt (p-Akt) in HUVECs exposed to HR. *P < 0.05 versus normoxic HUVECs (C [normoxic
conditions]), and HR; n ¼ 3. GADPH, glyceraldehyde 3-phosphate dehydrogenase.
JL Viñas et al.: ECFC exosomes transfer miR-486-5p bas i c re sea r chPTEN. ECFC-derived conditioned medium increased Akt
phosphorylation in HUVECs subjected to HR, whereas
conditioned medium from ECFCs transfected with anta-
gomiR to miR-486-5p blocked this effect (Figure 4b). HR
induced a signiﬁcant increase in caspase-3 activity in
HUVECs, and ECFC-derived conditioned medium
inhibited this effect (Figure 4c). On the other hand,
conditioned medium from ECFCs transfected with anta-
gomiR to miR-486-5p did not affect HR-stimulated
caspase-3 activity.
Tracking of ECFC-derived exosomes and transfer of
miR-486-5p to HUVECs
The transfer of miR-486-5p was further studied in co-cultures
of ECFCs and HUVECs, exposed to either the inhibitor of
exosome secretion GW4869,19,20 or the inhibitor of exosome
uptake 5-(N-ethyl-N-isopropyl)amiloride (EIPA).21–23 Sig-
niﬁcant increases in HUVEC levels of miR-486-5p were
observed in co-culture compared with HUVECs cultured
alone (Figure 5). Incubation of co-cultured cells with
GW4869 or EIPA blocked this increase. Transfection of
ECFCs with pre–miR-486-5p (which requires processing
to generate mature miR-486-5p) before co-culture withKidney International (2016) 90, 1238–1250HUVECs caused marked increases in HUVEC miR-486-5p
levels (w700-fold), which were signiﬁcantly inhibited by
GW4869 or EIPA.
Tracking of ECFC-derived exosomes into HUVECs was
studied using the red ﬂuorescent dye PKH26. In phalloidin-
stained HUVECs incubated with exosomes prelabeled with
PKH26, red ﬂuorescent particles were detected within
cytoplasm by confocal microscopy (Figure 6). Incubation of
HUVECs with PKH-labeled exosomes in the presence of
EIPA signiﬁcantly inhibited cytoplasmic red ﬂuorescent
staining, whereas GW4869 had no effect on uptake of
exosomes.
Targeting of PTEN by ECFC-derived exosomes in HUVECs
To test whether exosomal miR-486-5p directly targets PTEN
in HUVECs, a dual-reporter luciferase assay was performed,
using a reporter vector containing a complementary miR-
486-5p sequence in its 30-UTR (Figure 7a). When HUVECs
transfected with the reporter vector were incubated with
ECFC exosomes or with miR-486-5p mimic, luciferase
activity was signiﬁcantly reduced (Figure 7b). The inhibitory
effect of exosomes on HUVEC luciferase activity was blocked
when HUVECs were ﬁrst transfected with antagomiR to1241
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Figure 4 | Endothelial colony-forming cell (ECFC)–derived miR-486-5p reduces phosphatase and tensin homolog (PTEN), stimulates
Akt phosphorylation, and inhibits caspase-3 activation in endothelial cells subjected to hypoxia/reoxygenation (HR). Human umbilical
vein endothelial cells (HUVECs) were incubated under normoxic conditions (C) or in a hypoxic chamber for 24 hours, followed by return to
normoxia (HR). Upon reoxygenation, cells were incubated in either regular media (C/HR), ECFC-derived conditioned media (CM) (CM/HR), CM
from ECFCs treated with Lipofectamine alone (CMþLF/HR), CM from ECFCs transfected with antagomiR (AmiR) to miR-486-5p (CMþAmiR/HR),
or CM from ECFCs transfected with scrambled miRNA (CMþSCB/HR). (a) Expression of PTEN by immunoblot analysis. Representative blots
for PTEN and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are depicted. *P < 0.05 versus normoxic conditions (C), CM/HR and
CMþLF/HR; †P < 0.001 versus CMþSCB/HR; þP < 0.05 versus CM/HR, CMþLF/HR, and CMþSCB/HR; n ¼ 3. (b) Phosphorylation of Akt by
immunoblot analysis. Representative blots for phosphorylated Akt and total Akt are depicted. *P < 0.05 versus C/HR and CMþAmiR/HR; n ¼ 3.
(c) Caspase-3 activity. *P < 0.001 versus normoxic conditions (C), CM/HR, CMþLF/HR, and CMþSCB/HR; n ¼ 3.
bas i c re sea r ch JL Viñas et al.: ECFC exosomes transfer miR-486-5pmiR-486-5p. In contrast, neither exosomes nor transfection
of HUVECs with a miR-486-5p mimic reduced HUVEC
luciferase activity when cells were transfected with a mutated
vector of the PTEN 30-UTR (Figure 7c).
Role of PTEN in endothelial cell apoptosis
To determine the role of PTEN in endothelial cell apoptosis,
experiments were conducted in HUVECs in which PTEN
expression was decreased by small interfering RNA (siRNA)
before exposure to HR and treatment with ECFC exosomes.
Transfection of HUVECS with siRNA to PTEN reduced
PTEN protein expression (Supplementary Figure S2) and
eliminated caspase-3 activation in response to HR.
Furthermore, in HUVECs with knockdown of PTEN, exo-
somes had no effect on caspase-3 activation in response
to HR (Figure 8). In separate experiments, transfection of
HUVECs with scrambled siRNA or incubation with the
transfection vehicle Lipofectamine (Life Technologies Inc.,
Carlsbad, CA) had no effect on caspase-3 activation in response
to HR (data not shown, n ¼ 3).1242In vivo effect of ECFC exosomes and miR-486-5p on kidney IR
injury in mice
The potential impact of exosomal miR-486-5p transfer in
protection from kidney IR injury in vivo was studied in
immunocompetent FVB mice. Mice were subjected to kidney
IR (or sham surgery) and treated with or without ECFC
exosomes by jugular venous infusion at reperfusion. One
group of mice received exosomes derived from ECFCs that
were ﬁrst transfected with antagomiR to miR-486-5p, which
resulted in signiﬁcant depletion of exosomal miR-486-5p
levels (Supplementary Figure S3). Kidney levels of miR-486-
5p in FVB mice tended to increase 24 hours after IR,
although this did not reach statistical signiﬁcance. Exosome
administration caused a further signiﬁcant increase
(Figure 9). By contrast, treatment with exosomes derived
from ECFCs transfected with antagomiR did not induce a
change in kidney miR-486-5p levels. Kidney PTEN expression
was signiﬁcantly increased after IR, and exosome adminis-
tration inhibited expression. This inhibition was not observed
in mice treated with exosomes from ECFCs transfected withKidney International (2016) 90, 1238–1250
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Figure 5 | Exosomal transfer of miR-486-5p to cultured
endothelial cells. Graphs depict levels of miR-486-5p in human
umbilical vein endothelial cells (HUVECs) before (HUVEC alone) and
after co-culture with endothelial colony-forming cells (ECFCs), with or
without treatment with Lipofectamine alone (LF), or previous trans-
fection of ECFCs with scrambled miRNA (SCB [transfection with
scrambled miRNA sequence], negative control) or pre-miR-486-5p
(Pre-miR). (a) Effect of treatment with GW4869 (10 mM) during
co-culture. (b) Effect of 5-(N-ethyl-N-isopropyl)amiloride (EIPA) 10 mM
during co-culture. *P < 0.001 versus HUVEC alone (Vehicle),
þP < 0.001 versus the corresponding Vehicle group; n ¼ 5 each for
a and b.
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Figure 6 | Internalization of endothelial colony-forming cell
(ECFC)–derived exosomes by human umbilical vein endothelial
cells (HUVECs) is blocked by 5-(N-ethyl-N-isopropyl)amiloride
(EIPA) but not by GW4869. (a) Representative confocal microscopy
images of HUVECs stained with AlexaFluor 488 phalloidin (green):
untreated cells (C), HUVECs treated with ECFC-derived exosomes
(EX, 20 mg/ml) labeled with PKH26 (red), HUVECs pretreated with
10 mM EIPA before exposure to ECFC-derived PKH26-labeled exo-
somes (EXþEIPA), HUVECs pretreated with 10 mM GW4869 before
exposure to ECFC-derived PKH26-labeled exosomes (EXþGW4869).
Original magniﬁcation 630. Bars ¼ 10 mm. (b) Semiquantitative
analysis of imaging for PKH26-labeled exosomes in each condition.
*P < 0.001 versus C and EXþEIPA; n ¼ 3. AU, arbitrary units.
JL Viñas et al.: ECFC exosomes transfer miR-486-5p bas i c re sea r chantagomiR. Kidney Akt phosphorylation was increased in
mice treated with exosomes, but not in mice that received
exosomes from antagomiR-transfected ECFCs.
We previously showed that administration of ECFCs or
their exosomes to immunoincompetent NOD-SCID mice
with kidney IR injury has renal functional and histologic
protective effects.9 Accordingly, we measured levels of miR-
486-5p, PTEN, and phosphorylated Akt in kidneys from
these mice. Kidney miR-486-5p levels increased signiﬁcantly
24 hours after IR in NOD-SCID mice, and treatment with
ECFCs or exosomes after IR induced further signiﬁcant in-
creases (Supplementary Figure S4). As with FVB mice, exo-
somes (and ECFCs) inhibited kidney PTEN expression and
stimulated Akt phosphorylation in NOD-SCID mice
compared with IR alone.
As shown in Figure 10, administration of exosomes to FVB
mice with IR caused potent protection against kidney injuryKidney International (2016) 90, 1238–1250after 24 hours, as evidenced by normalization of plasma
creatinine and blood urea nitrogen, decreased inﬁltration of
neutrophils, and diminished histologic injury. Histologic
evidence of apoptosis and caspase-3 activation were also
reduced by exosome treatment (Figure 11). These protective
effects were signiﬁcantly attenuated in mice that received
exosomes derived from ECFCs that were transfected with
antagomiR to miR-486-5p.
DISCUSSION
Delivery of extracellular vesicles derived from endothelial
progenitor cells protects against experimental kidney IR1243
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Figure 8 | Role of phosphatase and tensin homolog (PTEN)
in endothelial cell apoptosis. Graph depicts caspase-3 activity
in human umbilical vein endothelial cells exposed to hypoxia/
reoxygenation (HR), with or without transfection with silencing RNA
(siRNA) to PTEN, and with or without preincubation for 24 hours with
endothelial colony-forming cell (ECFC) exosomes (EX, 20 mg/ml). C,
control; AFU, arbitrary ﬂuorescent units. *P < 0.05 versus all other
groups; n ¼ 3.
bas i c re sea r ch JL Viñas et al.: ECFC exosomes transfer miR-486-5pinjury, and transfer of miRNA to recipient cells has been
implicated in the reparative process.9,12,16 The current studies
indicate that transfer of miR-486-5p from ECFC-derived
exosomes to endothelial cells plays an important role in
preventing apoptosis after kidney IR. This conclusion is
supported by several observations: (i) ECFC-derived exo-
somes are highly enriched in miR-486-5p, and delivery of
exosomes to 2 separate mouse strains with kidney IR injury
or to cultured endothelial cells exposed to hypoxic injury
increases miR-486-5p levels, inhibits PTEN expression, and
enhances Akt phosphorylation; (ii) ECFC-derived condi-
tioned medium inhibits hypoxia-induced apoptotic responses
in cultured endothelial cells associated with inhibition of
PTEN expression and Akt activation, effects that are blocked
by miR-486-5p antagomiR; (iii) transfer of miR-486-5p from
ECFCs to endothelial cells occurs in co-culture and is blocked
by inhibitors of exosomal release and uptake; (iv) miR-486-5p
directly targets PTEN in cultured endothelial cells, and
knockdown of PTEN expression prevents HR-induced
apoptosis; and (v) ECFC exosomes potently protect against
kidney IR injury in mice, an effect that is lost when ECFCs are
ﬁrst transfected with antagomiR to miR-486-5p.
Several miRNA candidates have been implicated in kidney
IR injury including proangiogenic miR-126 and miR-296,12
proapoptotic miR-24,24 and miR-21 (antiapoptotic).25 We
did not detect miR-296 or miR-24 in our study, and although
miR-126 and miR-21 were found in ECFC-derived exosomes,1244 Kidney International (2016) 90, 1238–1250
2.0
1.5
1.0
0.5
0.0
PT
EN
 e
xp
re
ss
io
n
TE
N
 e
xp
re
ss
io
n 2.0
1.5
1.0
0.5
0.0
p-
A
kt
 e
xp
re
ss
io
n
-A
kt
 e
xp
re
ss
io
n
a
b C
15
10
5
0
Sh
am I
R
IR
+E
X
IR
+E
X+
Am
iR
Sh
am IR
IR
+E
X
IR
+E
X+
Am
iR
Sh
am IR
IR
+E
X
IR
+E
X+
Am
iR
Sham IR IR+EX IR+EX+AmiR Sham IR IR+EX IR+EX+AmiR
PTEN (54 kDa)
β-Actin (42 kDa)
p–Akt (60 kDa)
Akt (56 kDa)
m
iR
-4
86
-5
p 
le
ve
l
iR
-4
86
-5
p 
le
ve
l
Figure 9 | Effect of endothelial colony-forming cell (ECFC) exosomes, with or without previous transfection with miR-486-5p
antagomiR, on kidney miR-486-5p, phosphatase and tensin homolog (PTEN), and phosphorylated Akt (p-AKT) after ischemia/
reperfusion (IR) in FVB mice. (a) Graph depicts kidney levels of miR-486-5p in sham-treated FVB mice (Sham), FVB mice with kidney IR, FVB
mice with kidney IR treated with ECFC exosomes at the time of reperfusion (IRþEX), and FVB mice with kidney IR treated with exosomes derived
from ECFCs transfected with antagomiR (AmiR) to miR-486-5p (IRþEXþAmiR) 24 hours after IR. *P < 0.05 versus IR, IRþEXþAmiR; þP < 0.01
versus Sham; n ¼ 5–7. (b) Graph shows kidney PTEN expression in the 4 groups of FVB mice, with representative immunoblot above for PTEN
and loading control (b-actin). *P < 0.01 versus Sham, IRþEX; þP < 0.05 versus Sham, IRþEX; n ¼ 5–7. (c) Graph shows kidney phosphorylated
Akt (p-Akt) in the 4 groups of FVB mice, with representative immunoblot above for p-Akt and loading control (total Akt). *P < 0.01 versus
Sham, þP < 0.05 versus IR, IRþEXþAmiR; n ¼ 5–7.
JL Viñas et al.: ECFC exosomes transfer miR-486-5p bas i c re sea r chlevels were not increased compared with ECFCs or MPs.
However, using an unbiased approach, we demonstrated that
ECFC exosomes are highly enriched in miR-486-5p compared
with ECFCs or MPs. Although other differentially expressed
miRs, mRNAs, or proteins in exosome cargo could play a role
in the protective effects on IR injury, miR-486-5p is a
compelling candidate for mediating antiapoptotic effects
in vivo and in vitro. Thus, miR-486-5p has been shown to
target PTEN in skeletal muscle, which, in turn, enhances the
antiapoptotic phosphoinositide 3-kinase/Akt pathway.18 This
pathway is particularly relevant to AKI because enhanced Akt
phosphorylation is associated with improved kidney function
in mice with IR injury.26
Our data indicate direct targeting of endothelial cell PTEN
by exosomal miR-486-5p, suggesting that this leads to
enhanced Akt phosphorylation and inhibition of apoptosis.
Thus, delivery of exosomes to mice with kidney IR injury was
associated with reduced kidney expression of PTEN and
enhanced Akt phosphorylation, accompanied by increased
levels of miR-486-5p. In cultured HUVECs exposed to HR,
ECFC exosomes or conditioned media increased miR-486-5pKidney International (2016) 90, 1238–1250levels, and the effects of ECFC conditioned media on PTEN,
Akt, and caspase-3 activity were reversed by pretransfection of
ECFCs with miR-486-5p antagomiR. Knockdown of PTEN in
HUVECs was associated with decreased apoptotic response.
Despite these data, the earliest time point of Akt activation by
exosomes in relation to PTEN suppression was not deﬁned in
our study. Thus, although Akt phosphorylation appears to be
a downstream event related to PTEN inhibition,17,18 the link
between these 2 signaling targets in apoptosis after kidney IR
requires further study.
Although our data suggest that reduced PTEN expression
may be protective immediately after IR, the long-term conse-
quences of PTEN suppression remain unclear. In a rat model
of kidney IR, Lan et al.27 showed that persistent loss of PTEN
in proximal tubules leads to growth arrest and a proﬁbrotic
phenotype, which may contribute to chronic kidney disease
after AKI. Optimal dosing and timing of delivery of exosomes
enriched in miR-486-5p after AKI should therefore be further
investigated to mitigate such potential late adverse effects.
In our in vivo studies, FVB mice had increased kidney
PTEN expression after IR, despite a tendency for increased1245
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Figure 10 | Effects of endothelial colony-forming cell (ECFC) exosomes on parameters of kidney injury in FVB mice with ischemia/
reperfusion (IR): role of miR-486-5p. (a) Graph shows plasma creatinine levels in sham-treated FVB mice (Sham), FVB mice with kidney IR,
FVB mice with kidney IR treated with ECFC exosomes at the time of reperfusion (IRþEX), and FVB mice with kidney IR treated with exosomes
derived from ECFCs transfected with antagomiR (AmiR) to miR-486-5p (IRþEXþAmiR) 24 hours after IR. *P < 0.05 versus Sham, IRþEX;
þP < 0.05 versus IRþEX; n ¼ 5–7. (b) Graph shows blood urea nitrogen (BUN) in the 4 groups of FVB mice, 24 hours after IR. (Continued)
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Figure 11 | Protective effects of endothelial colony-forming cell (ECFC) exosomes on apoptosis in FVB mice with kidney ischemia/
reperfusion (IR) injury: role of miR-486-5p. (a) Graph depicts semiquantitative assessment of terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling (TUNEL) staining in kidneys from sham-treated FVB mice (Sham), FVB mice with kidney IR, FVB mice with kidney IR
treated with ECFC exosomes at the time of reperfusion (IRþEX), and FVB mice with kidney IR treated with exosomes derived from ECFCs
transfected with antagomiR (AmiR) to miR-486-5p (IRþEXþAmiR) 24 hours after IR. Results are depicted as TUNEL-positive nuclei per high-
powered ﬁeld (HPF). *P < 0.001 versus Sham, IRþEX; n ¼ 5–7. (b) Representative photomicrographs of kidney TUNEL imaging from FVB mice.
Arrows indicate TUNEL-positive nuclei, indicative of apoptosis (sham kidneys had only few TUNEL-positive nuclei). Original magniﬁcation 600.
Bar ¼ 10 mm. (c) Graph depicts kidney caspase-3 activity in the 4 groups of FVB mice 24 hours after IR. *P < 0.05 versus Sham, IRþEX; n ¼ 5–7.
AFU, arbitrary ﬂuorescent units.
=
JL Viñas et al.: ECFC exosomes transfer miR-486-5p bas i c re sea r chmiR-486-5p levels, compared with sham-treated mice. In
NOD-SCID mice with kidney IR, we also observed increased
PTEN expression, with signiﬁcantly enhanced kidney miR-
486-5p levels. Thus, miR-486-5p levels may have to achieve
a threshold before signiﬁcantly affecting PTEN expression in
the kidney after IR. Moreover, in addition to PTEN, other
potential targets of miR-486-5p should be considered in the
overall protective response. Alternate targets for miR-486-5p
include the transcription factor FoxO1, which has been
implicated in miR-486/PTEN/Akt signaling and muscleFigure 10 | (Continued) *P < 0.01 versus Sham, IRþEX; þP < 0.05 versus S
the 4 groups of FVB mice depicted as numbers of neutrophils per high-
histologic kidney injury scores in the 4 groups of FVB mice. *P < 0.01 v
periodic acid–Schiff–stained kidney tissue from the 4 groups of mice. Arro
and arrowheads indicate nuclear loss. Original magniﬁcation 200. Bar
Kidney International (2016) 90, 1238–1250wasting in chronic kidney disease,28 and SMAD2, which is
associated with attenuation of transforming growth factor-
b1–induced ﬁbroblast proliferation and experimental lung
ﬁbrosis.29 In hepatocellular carcinoma tissue, miR-486-5p
directly targets phosphoinositide K3R1, leading to suppres-
sion of phosphoinositide 3-kinase/Akt activation and inhibi-
tion of cell growth.30
Our study focused on endothelial cells as major targets of
exosomal transfer of miR-486-5p after ischemic injury.
However, the renal endothelium may not be the sole target forham, IRþEX; n ¼ 5–7. (c) Graph shows kidney neutrophil inﬁltration in
power ﬁeld. *P < 0.01 versus Sham, IRþEX; n ¼ 5–7. (d) Graph shows
ersus Sham, IRþEX; n ¼ 5–7. (e) Representative photomicrographs of
ws indicate hallmark tubular dilation, asterisks indicate cast formation,
¼ 30 mm.
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kidney IR injury, Cantaluppi et al.12 localized infused
microvesicles from endothelial progenitor cells to both peri-
tubular capillaries and tubular cells, suggesting that renal
epithelial or interstitial cells could also be recipients of exo-
somal miR transfer after IR. In addition, in our studies, levels
of miR-486-5p in cultured endothelial cells were not
enhanced after hypoxia, whereas whole kidney levels of miR-
486-5p increased in NOD-SCID mice and tended to increase
in FVB mice after IR. These data suggest that kidney cells
other than the endothelium may be induced to express miR-
486-5p in the endogenous reparative response.
In the current studies, HUVEC miR-486-5p levels
increased when cells were co-cultured with ECFCs and even
more profoundly when ECFCs were ﬁrst transfected with a
pre-miR for miR-486-5p. Incubation of co-cultured cells with
GW4869, which blocks exosome biogenesis by inhibiting
neutral sphingomyelinase 2,19,20 signiﬁcantly lowered
HUVEC miR-486-5p levels. The speciﬁcity of this inhibitory
effect on exosome release was supported by confocal imaging.
By contrast EIPA, an inhibitor of the Naþ-Hþ exchanger and
macropinocytosis21–23 decreased HUVEC miR-486-5p levels
in co-cultured cells and blocked exosome uptake into
HUVECs. Although plasma miRNAs have been reported to
largely circulate in association with Argonaute2, which en-
sures their stability outside of vesicles,31 our data indicate that
miR-486-5p is selectively enriched within ECFC exosomes,
which transfer this miRNA to endothelial cells.
In summary, human cord blood ECFCs produce exosomes
enriched in miR-486-5p. In vitro studies reveal exosomal
transfer of miR-486-5p to endothelial cells, with targeting
of the PTEN/Akt pathway. Delivery of exosomes to mice
with kidney IR injury exerts potent protective effects associ-
ated with decreased kidney PTEN and activation of Akt.
These effects are not observed with exosomes depleted of
miR-486-5p. The results suggest that the use of human
miR-486-5p–containing exosomes may be a viable strategy to
protect against endothelial injury in AKI.MATERIALS AND METHODS
Next-generation sequencing and bioinformatics
Template libraries were prepared from total RNA from ECFCs,
exosomes, and MPs, using the Truseq Small RNA kit (Illumina Inc.,
San Diego, CA). Two independent libraries were generated from
ECFC-derived exosomes and MPs (2 independent cultures) and
compared with a library of ECFC small RNA. Adapters speciﬁcally
targeting miRNAs and other small RNAs were ligated to each end of
the RNA molecule, and an RT reaction was used to create single-
stranded cDNA. Adapter-ligated fragments were ampliﬁed using
15 cycles of PCR. Enriched cDNA constructs were puriﬁed by
Tris/borate/ethylenediamine tetraacetic acid polyacrylamide gel
electrophoresis, selecting the bands corresponding to input miRNA
fragments of 22 to 30 nucleotides. Cluster generation was performed
using the Illumina Cbot, and 36 cycles of single-end sequencing were
performed with the Illumina Genome Analyzer IIx. The reads from
each sample were aligned to mature human miRNAs in miRBase
version 20 using Bowtie 0.12.7 software. Only trimmed reads1248with $18 bases were considered, and no mismatches were tolerated
in the alignment.
In vivo kidney IR studies
Bilateral kidney IR was performed on 8- to 10-week-old male FVB
mice (Charles River, St. Constant, QC, Canada), essentially as
described in our previous study on NOD-SCID mice.9 Immediately
after restoration of blood ﬂow, mice received either vehicle (phos-
phate-buffered saline 100 ml), ECFC exosomes (20 mg), or exosomes
(20 mg) derived from ECFCs that were ﬁrst transfected with anta-
gomiR to miR-486-5p (miRCURY LNA microRNA inhibitor, Exi-
qon, Vedbaek, Denmark) (Supplementary Figure S5). All infusions
were given by jugular vein, and mice were killed 24 hours after
reperfusion. Sham mice were subjected to surgery without renal
vascular clamping. Protocols were approved by the Animal Ethics
Committee at the University of Ottawa and performed according to
the recommendations of the Canadian Council for Animal Care.
Plasma biochemistry
Plasma creatinine and blood urea nitrogen levels were measured by
IDEXX Laboratories (Markham, ON, Canada).
Histology
Mouse kidneys were ﬁxed in 4% formalin, dehydrated, embedded in
parafﬁn, and stained as described.9 Histologic injury was performed
semiquantitatively in a blinded fashion by a renal pathologist (AG)
with scoring on a scale of 0 to 4.9 Neutrophil inﬁltration was assessed
on kidney sections by quantitation of myeloperoxidase staining in a
blinded fashion (polyclonal rabbit myeloperoxidase antibody, 1:200,
Neomarker, Fremont, CA). Apoptosis was measured using the ter-
minal deoxynucleotidyl transferase–mediated dUTP nick-end label-
ing (TUNEL) ApopTag kit (EMD Millipore, Temecula, CA). Images
were acquired at room temperature on a Zeiss Imager A1 with a
Zeiss AxioCam HRc using Axiovision version 1.6 (Carl Zeiss AG,
Oberkochen, Germany).
Cell culture
ECFCs were cultured (passages 3–5) from human umbilical cord
blood units obtained at The Ottawa Hospital and Queensway Car-
leton Hospital (Ottawa, ON, Canada) following informed written
consent and with approval from the institutional research ethics
boards and characterized as described.9,32 HUVECs were obtained
from the American Type Culture Collection (Manassas, VA) and
cultured as described.9 For experiments involving co-culture of
ECFCs and HUVECs, ECFCs were seeded onto 0.4-mm Transwell
culture inserts (Corning, Tewksbury, MA) and treated with vehicle
or Lipofectamine 2000 (Life Technologies Inc., Carlsbad, CA) alone
or transfected with pre-miR-486-5p (Life Technologies, Inc.) or
scrambled sequence (Supplementary Figure S5). After 24 hours,
the inserts were transferred to dishes seeded with HUVECs, and
co-cultured for 24 hours. During co-culture, cells were treated with
or without GW4869 (10 mM, Cayman Chemical, Ann Arbor, MI) or
EIPA (10 mM, Sigma, Oakville, ON, Canada). In some experiments,
ECFCs were transfected with antagomiR to miR-486-5p, 24 hours
before collection of exosomes from the cell media.
Silencing RNA
HUVEC PTEN expression was decreased by transfection of cells with
siRNA (Silencer Select Pre-designed siRNA, Ambion Inc., Foster
City, CA).Kidney International (2016) 90, 1238–1250
JL Viñas et al.: ECFC exosomes transfer miR-486-5p bas i c re sea r chExosome and MP isolation
Exosomes and MPs were isolated from ECFC-conditioned medium
by successive centrifugations, as described,9 after 24 hours of culture
in the presence of vesicle-depleted fetal bovine serum (System
Biosciences, Mountain View, CA).
Nanoparticle tracking analysis
Sizing of extracellular vesicles was performed by nanoparticle
tracking analysis with a Nanosight LM10 instrument (NanoSight
Ltd., Amesbury, UK), as described.9,33,34
miRNA isolation and real-time PCR
Total RNA inclusive of the small RNA fraction was extracted using
the miRNeasy Mini Kit (Qiagen Inc., Toronto, ON, Canada). The
TaqMan MicroRNA Reverse Transcription Kit (Life Technologies,
Inc.) was used for cDNA preparation. Real-time PCR reactions were
performed in an Applied Biosystems 7000 sequence detection real-
time PCR system (Foster City, CA). Mamm-U6 RNA was used to
normalize differences in RNA levels of each sample. The relative
amount of miRNA to U6 RNA was expressed using the 2  DDCt
method.35
Hypoxia-reoxygenation
HUVECs were rendered hypoxic for 24 hours (0.5% O2). Some cells
were incubated during this time with conditioned medium from
ECFCs, conditioned medium from ECFCs previously transfected
with miR-486 antagomiR, or medium containing ECFC-derived
exosomes (20 mg/ml).36 After 24 hours of hypoxia, HUVECs were
placed under standard culture conditions for an additional 24 hours.
Immunoblots
Kidney and HUVEC lysates were run on polyacrylamide gel
electrophoresis gels and incubated with antibodies directed against
Akt (1:1000, Cell Signaling, Beverly, MA), phosphorylated Akt
(Ser473) (1:1000, Cell Signaling), PTEN (1:1000, Cell Signaling),
b-actin (1:2000, Sigma), or glyceraldehyde 3-phosphate dehydroge-
nase (1:1000, Millipore, Toronto, ON, Canada) for 16 hours at
4C. Exosome fractions were incubated with antibody to TSG101
(1:1000, Abcam Inc., Toronto, ON, Canada). Washed membranes
were incubated with horseradish peroxidase–conjugated secondary
antibodies (1:2000, Jackson ImmunoResearch, West Grove, PA) and
probed by chemiluminescence. Blots were analyzed using ImageJ
software (NIH, Bethesda, MD) and corrected for loading controls.
Caspase-3 activity
Caspase-3 activity was measured using the QuantiZyme Assay
System (BioMol, Farmingdale, NY).9
Tracking of exosomes
Exosomes were labeled with the red ﬂuorescent dye PKH26
(Sigma)37 for 5 minutes at room temperature. After ultracentrifu-
gation, exosomes were resuspended in phosphate-buffered saline and
incubated with HUVECs (20 mg/ml) for 4 hours at 37C. Cells were
stained with Alexa Fluor 488 phalloidin (Life Technologies Inc.).
Imaging was performed using an LSM 510 Meta/AxioVert200
confocal microscope (Carl Zeiss AG, Oberkochen, Germany) and
analyzed with Zen 2009 software (Carl Zeiss).
Luciferase assay
Transfection studies were conducted using ﬁreﬂy luciferase as a reporter
gene, with normalization using Renilla Luciferase (GeneCopoeia,Kidney International (2016) 90, 1238–1250Rockville, MD). The pEZX- MT06-PTEN 30UTR-f/rLuc or mutant
PTEN 30UTR vectors (100 ng, GeneCopoeia) were transfected
into HUVECs with Lipofectamine 2000 alone, or with mimic to
miR-486-5p (2 pmol) (Qiagen, Hilden, Germany) (Supplementary
Figure S5). After 24 hours, luciferase activity was assayed using
a Dual Luminescence assay kit (GeneCopoeia). Readings were
performed on an Orion II microplate luminometer (Berthold Detec-
tion Systems, Pforzheim, Germany).
Statistical analysis
Results are expressed as mean  SEM and were analyzed using 1- or
2-way analysis of variance with Bonferroni’s posttest as appropriate.
Statistical analyses were performed with GraphPad Prism 5.0
(GraphPad Software, Inc., San Diego, CA). P < 0.05 was considered
signiﬁcant.
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Figure S1. Small RNA sequencing results. List of miRNA species
identiﬁed in endothelial colony-forming cells (ECFCs), ECFC-derived
exosomes, ECFC-derived microparticles or combinations thereof, by
Next Generation Sequencing.
Figure S2. Knockdown of phosphatase and tensin homolog (PTEN)
expression by silencing RNA in cultured human umbilical vein
endothelial cells (HUVECs). Depicted is immunoblot for PTEN, with
loading control immunoblot (glyceraldehyde 3-phosphate dehydro-
genase [GAPDH]) below. Lane 1 is from untransfected HUVECs. Lane 2
is from HUVECs exposed to Lipofectamine alone. Lanes 3, 4, and 5 are
from 3 separate cultures of HUVECs transfected with silencing RNA
(siRNA, 5 nM) against PTEN. Lane 6 is from HUVECs transfected with
scrambled siRNA (5 nM).
Figure S3. Reduced miR-486-5p levels in exosomes derived from
endothelial colony-forming cells (ECFCs) transfected with antagomiR
(AmiR) to miR-486-5p. Graph depicts results of real-time polymerase
chain reaction for miR-486-5p in exosomes from ECFCs (ECFC/EX) and
from ECFCs transfected with miR-486-5p antagomiR (ECFCþAmiR/EX),
corrected for U6 RNA. *P < 0.01; n ¼ 3.
Figure S4. ECFCs and their exosomes increase kidney miR-486-5p
levels, decrease phosphatase and tensin homolog (PTEN), and
enhance Akt phosphorylation after ischemia/reperfusion (IR) in
nondiabetic severe combined immunodeﬁcient mice. (A) Real-time
polymerase chain reaction for miR-486-5p performed on mouse
kidney RNA, 24 hours after IR and endothelial colony-forming cell
(ECFC) treatment (IR þ ECFCs). *P < 0.01, **P < 0.001 versus
Sham, þP < 0.01 versus IR. (B) Effect of ECFC exosome treatment
(IR þ EX) on kidney miR-486-5p levels after IR. *P < 0.01 versus
Sham, þP < 0.01 versus IR. (C) Effect of ECFC treatment (IR þ ECFC)
on kidney PTEN expression 24 hours after IR. *P < 0.01 versus IR þ
ECFC or Sham. (D) Effect of ECFC exosomes (IR þ EX) on kidney PTEN
expression 24 hours after IR. *P < 0.01 versus IR þ EX or Sham. (E)
Effect of ECFC treatment (IR þ ECFC) on kidney phosphorylated Akt1249
bas i c re sea r ch JL Viñas et al.: ECFC exosomes transfer miR-486-5p(p-Akt) 24 hours after IR. *P < 0.05 versus IR; þP < 0.01 versus Sham.
(F) Effect of ECFC exosomes (IR þ EX) on kidney p-Akt 24 hours after
IR. *P < 0.05 versus IR; þP < 0.01 versus Sham. Six to 7 kidney
samples for each condition in each panel. Representative immuno-
blots for PTEN and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) controls are shown for C and D and for p-Akt and total Akt
for E and F.
Figure S5. Nucleotide sequences and plasmid constructs. Nucleotide
sequences for pre-miR-486-5p, miR-486-5p mimic, and miR-486-5p
antagomiR are shown at top, with luciferase constructs below. An
8-nucleotide sequence within the 30 untranslated region (UTR) of
phosphatase and tensin homolog (PTEN) was inserted into the
pEZX-MT06-f/r-luciferase reporter plasmid. The binding sequence
for miR-486-5p is underlined. A mutated sequence was inserted
(underlined) to generate the pEZX-MT06-PTEN30UTRmut plasmid.
Supplementary material is linked to the online version of the paper at
www.kindey-international.org.REFERENCES
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